Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teun van Gelder

Showing results (11-20 of 324) with videos related to

Pageof 33
Sort By:
Transplantation|March 3, 2010
TDM for mycophenolic acid at no extra costTeun van Gelder
British Journal of Clinical Pharmacology|September 8, 2017
Biomarkers in solid organ transplantationTeun van Gelder
Transplantation|April 5, 2017
Causes and Consequences of the Worldwide Belatacept ShortageSteven Gabardi, Teun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|February 28, 2013
Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugsTeun van Gelder, Steven Gabardi
Pediatric Nephrology (Berlin, Germany)|February 27, 2018
Clinical aspects of tacrolimus use in paediatric renal transplant recipientsAgnieszka Prytuła, Teun van Gelder
Transplantation|June 22, 2016
Belatacept: A Game Changer?Teun Van Gelder, Dennis A Hesselink
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Should it be mandatory to document off-label prescription in the patient's medical file?]Teun van Gelder, Frouke M Engelaer
Clinical Pharmacology and Therapeutics|October 4, 2005
Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acidDennis A Hesselink, Teun van Gelder
Transplantation|October 28, 2005
The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantationTeun van Gelder, Leslie M Shaw
Transplant International : Official Journal of the European Society for Organ Transplantation|March 12, 2015
Mycophenolate revisitedTeun van Gelder, Dennis A Hesselink
Pageof 33

Showing results (11-20 of 324) with videos related to

Sort By:
Pageof 33
Transplantation|March 3, 2010
TDM for mycophenolic acid at no extra costTeun van Gelder
British Journal of Clinical Pharmacology|September 8, 2017
Biomarkers in solid organ transplantationTeun van Gelder
Transplantation|April 5, 2017
Causes and Consequences of the Worldwide Belatacept ShortageSteven Gabardi, Teun van Gelder
Transplant International : Official Journal of the European Society for Organ Transplantation|February 28, 2013
Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugsTeun van Gelder, Steven Gabardi
Pediatric Nephrology (Berlin, Germany)|February 27, 2018
Clinical aspects of tacrolimus use in paediatric renal transplant recipientsAgnieszka Prytuła, Teun van Gelder
Transplantation|June 22, 2016
Belatacept: A Game Changer?Teun Van Gelder, Dennis A Hesselink
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Should it be mandatory to document off-label prescription in the patient's medical file?]Teun van Gelder, Frouke M Engelaer
Clinical Pharmacology and Therapeutics|October 4, 2005
Genetic and nongenetic determinants of between-patient variability in the pharmacokinetics of mycophenolic acidDennis A Hesselink, Teun van Gelder
Transplantation|October 28, 2005
The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantationTeun van Gelder, Leslie M Shaw
Transplant International : Official Journal of the European Society for Organ Transplantation|March 12, 2015
Mycophenolate revisitedTeun van Gelder, Dennis A Hesselink
Pageof 33